Institute For Gene And Cell Therapies
Washington, District of Columbia
BHealth Score
63B
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Above Average
💰
$1.4M
Total Revenue
📊
$1.2M
Total Expenses
🏦
$594K
Net Assets
📋
$252K
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Revenue Growth
+5.7%
Year-over-year change (2022 → 2023)
Net Margin
+17.3%
Revenue minus expenses as % of revenue
Working Capital Ratio
0.51
Net assets divided by total expenses
Liabilities-to-Assets
29.8%
Total liabilities as % of total assets
Filing History
5 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $1,400,439↑6% | $1,158,630↑5% | $846,401↑57% | — |
| 2022 | $1,325,000↑10% | $1,103,289↓1% | $538,185↑89% | — |
| 2021 | $1,200,000↑118% | $1,118,949↑28% | $285,097↓40% | — |
| 2020 | $550,000↑8% | $871,510↑528% | $475,691↑28% | — |
| 2019 | $510,000 | $138,823 | $371,177 | — |
Frequently Asked Questions
What does Institute For Gene And Cell Therapies do?▼
Institute For Gene And Cell Therapies is a medical research nonprofit organization based in District of Columbia. It is classified under NTEE code H92 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Institute For Gene And Cell Therapies financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Institute For Gene And Cell Therapies.
How much revenue does Institute For Gene And Cell Therapies generate?▼
Institute For Gene And Cell Therapies reports $1.1M in annual revenue and holds $875K in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in District of Columbia.